CK Life Sciences International Holdings (HKSE:00775) Interest Expense : HK$-322 Mil (TTM As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is CK Life Sciences International Holdings Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. CK Life Sciences International Holdings's interest expense for the six months ended in Dec. 2023 was HK$ -181 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-322 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. CK Life Sciences International Holdings's Operating Income for the six months ended in Dec. 2023 was HK$ 100 Mil. CK Life Sciences International Holdings's Interest Expense for the six months ended in Dec. 2023 was HK$ -181 Mil. CK Life Sciences International Holdings's Interest Coverage for the quarter that ended in Dec. 2023 was 0.55. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

CK Life Sciences International Holdings Interest Expense Historical Data

The historical data trend for CK Life Sciences International Holdings's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CK Life Sciences International Holdings Interest Expense Chart

CK Life Sciences International Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-158.88

-128.73

-97.82

-163.09

-322.43

CK Life Sciences International Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Interest Expense	Get a 7-Day Free Trial															-48.97	-52.20	-110.89	-141.69	-180.74

CK Life Sciences International Holdings Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-322 Mil.

CK Life Sciences International Holdings (HKSE:00775) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

CK Life Sciences International Holdings's Interest Expense for the six months ended in Dec. 2023 was HK$-181 Mil. Its Operating Income for the six months ended in Dec. 2023 was HK$100 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was HK$4,709 Mil.

CK Life Sciences International Holdings's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	99.984	/	-180.738
	=	0.55

The higher the ratio, the stronger the company's financial strength is.

CK Life Sciences International Holdings (HKSE:00775) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CK Life Sciences International Holdings Inc (HKSE:00775) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

LSI:Germany

Address

2 Dai Fu Street, Tai Po Industrial Estate, Tai Po, Hong Kong, HKG

Website

https://www.ck-lifesciences.com

CK Life Sciences International Holdings Inc is a biotechnology company engaged in the research & development, commercialization, and sale of health and agricultural-related products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. The company operates three core businesses, including agriculture, nutraceutical, and pharmaceutical. Its overall product portfolio involves a presence that spans North America and the Asia Pacific. The company uses mergers and acquisitions when it identifies attractive market opportunities.

CK Life Sciences International Holdings (HKSE:00775) Headlines

No Headlines